Debt Compromise Leaves FDA Funding, Medicare Dual Eligible Rebates in Limbo

The FDA would face difficulty receiving additional funds from Congress, possibly jeopardizing inspections and hiring, under a debt ceiling compromise reached by Congressional leaders Sunday.
Drug Industry Daily